The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new ...

WARN notices provide a heads up that staff will soon be unemployed, but the act that mandates them has some nuances. An ...

After two patients who received the investigational CDC7 blocker died, pushing forward with SGR-2921’s development would be ...

The HHS secretary recently canceled $500 million worth of BARDA contracts around mRNA vaccine research. But the U.S.

In this episode of Denatured, BioSpace’s head of insights Lori Ellis discusses the ‘enormous implications’ of patent policy ...

Citing other priorities—such as the upcoming U.S.-Russia summit—four anonymous sources claim that pharma tariffs could still ...

The death was linked to acute kidney injury in a patient who had a single kidney remaining and a “complex medical history,” ...

Vedanta is parting ways with 23 employees, or approximately 20% of its headcount, after Phase II data for microbiome therapy ...

In May 2025, the White House announced a ‘Most Favored Nation’ approach for setting prescription drug prices. The order aims ...

Looking for a biopharma job in Texas? Check out the BioSpace list of six companies hiring life sciences professionals like ...

The layoffs will not spare Generation’s R&D team, which will initially be retained while the biotech completes its strategic ...

CBER Chief Vinay Prasad reclaimed his job less than two weeks after his mysterious exit; MAHA implementor Gray Delany is out ...